Telix Pharmaceuticals Ltd — Share Issue/Capital Change 2025

May 15, 2025

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Announcement Summary

Entity name

TELIX PHARMACEUTICALS LIMITED

Announcement Type

New announcement

Date of this announcement

Friday May 16, 2025

The +securities to be quoted are:

+Securities issued, transferred or re-classified as a result of options being exercised or other +convertible securities being converted

Total number of +securities to be quoted

ASX +security		Number of +securities to
code	Security description	be quoted	Issue date
TLX	ORDINARY FULLY PAID	139,383	12/05/2025

Refer to next page for full details of the announcement

Appendix 2A - Application for quotation of securities

1 / 7

Appendix 2A - Application for quotation of securities

Part 1 - Entity and announcement details

==> picture [21 x 22] intentionally omitted <==

1.1 Name of entity

TELIX PHARMACEUTICALS LIMITED

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

1.2 Registered number type

Registration number

ACN 616620369

1.3 ASX issuer code

TLX

1.4 The announcement is

New announcement

1.5 Date of this announcement

16/5/2025

Appendix 2A - Application for quotation of securities

2 / 7

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Part 2 - Type of Issue

2.1 The +securities to be quoted are:

+Securities issued, transferred or re-classified as a result of options being exercised or other +convertible securities being converted

2.2 The +class of +securities to be quoted is:

Additional +securities in a class that is already quoted on ASX ("existing class")

Appendix 2A - Application for quotation of securities

3 / 7

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an Appendix 3B

Existing +securities converting into additional +securities in an existing class FROM (Existing Class) ASX +security code and description TLXAO : SHARE APPRECIATION RIGHTS

TO (Existing Class) ASX +security code and description TLX : ORDINARY FULLY PAID Please state the number of options The first date the options were The last date the options were that were exercised or other exercised or other +convertible exercised or other +convertible +convertible securities that were securities were converted securities were converted converted 2/5/2025 12/5/2025 127,818 Is this all of the options or other +convertible securities on issue of that type (ie have all of those options now been exercised or have all of those convertible securities now been converted)? No The right of the holder of the options or other +convertible securities to receive the +underlying securities is being satisfied by: An issue of new +securities The underlying +securities being received by the holder are: Intended to be, but are not yet, quoted by ASX Were the options being exercised or other +convertible securities being converted issued under an +employee incentive scheme? Yes Are any of the options being exercised or other +convertible securities being converted held by +key management personnel (KMP) or an +associate? No

Issue date

12/5/2025

Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class? Yes

Appendix 2A - Application for quotation of securities

4 / 7

Appendix 2A - Application for quotation of securities

Issue details

==> picture [21 x 22] intentionally omitted <==

Number of +securities to be quoted 105,671 Are the +securities being issued for a cash consideration? No

Please describe the consideration being provided for the +securities

Shares issued from exercise of vested 2022 PSARs under Telix Equity Incentive Plan valued using a $4.95 notional exercise price in accordance with the independent Black Scholes methodology Please provide an estimate (in AUD) of the value of the consideration being provided per +security for the +securities to be quoted 4.950000 Any other information the entity wishes to provide about the +securities to be quoted Refer https://ir.telixpharma.com/reports for AGM documentation and also Telix 2024 Remuneration report within the 2024 Annual Report Existing +securities converting into additional +securities in an existing class FROM (Existing Class) ASX +security code and description TLXAO : SHARE APPRECIATION RIGHTS

TO (Existing Class) ASX +security code and description TLX : ORDINARY FULLY PAID Please state the number of options The first date the options were The last date the options were that were exercised or other exercised or other +convertible exercised or other +convertible +convertible securities that were securities were converted securities were converted converted 5/5/2025 12/5/2025 43,323 Is this all of the options or other +convertible securities on issue of that type (ie have all of those options now been exercised or have all of those convertible securities now been converted)? No The right of the holder of the options or other +convertible securities to receive the +underlying securities is being satisfied by: An issue of new +securities

The underlying +securities being received by the holder are: Intended to be, but are not yet, quoted by ASX

Were the options being exercised or other +convertible securities being converted issued under an +employee incentive scheme? Yes

Are any of the options being exercised or other +convertible securities being converted held by +key management personnel (KMP) or an +associate? No

Issue date

12/5/2025

Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued

Appendix 2A - Application for quotation of securities

5 / 7

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

+securities in that class? Yes

Issue details

Number of +securities to be quoted

33,712

Are the +securities being issued for a cash consideration?

No

Please describe the consideration being provided for the +securities

Shares issued from exercise of vested 2022 PSARs under Telix EIP are valued in accordance with the independent Black Scholes methodology disclosed in the AGM Notice of Meeting held 18 May 2022.

Please provide an estimate (in AUD) of the value of the consideration being provided per +security for the +securities to be quoted

6.150000

Any other information the entity wishes to provide about the +securities to be quoted

Refer https://ir.telixpharma.com/reports for AGM documentation and also Telix 2024 Remuneration report within the 2024 Annual Report

Appendix 2A - Application for quotation of securities

6 / 7

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Part 4 - Issued capital following quotation

Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise:

The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.

4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application)

				+securities thbelow are autoG or Appendixumber of eachiti	e subjecmatically3H forms+class	t of this applgenerated anare currentlyof +securities	ication, the isd may not reflwith ASX for pquoted on A	sued capital of the enect the entity's current irocessing.SX following the +qu	tity willssued caotation o	pital iff the
	FollowincomprisThe figurother Ap4.1 Quotiti		g the quotation of thee:es in parts 4.1 and 4.2pendix 2A, Appendix 3ed +securities (total nbt f thi
	+securASX +seTLX : O4.2 Unqu		es sujec o s app	caon)						ber ofissue09,048ber of
		ASX +seTLX : O4.2 Unqu	curity code and descrRDINARY FULLY PAIDoted +securities (total	iptionnumber of ea	ch +clas	s of +securit	ies issued bu	T+secut not quoted on ASX)T	otal numrities on338,1otal num	ber ofissue09,048ber of
		ASX +security code and description+securities on issueTLXAQ : SHARE RIGHTS EXPIRING 13-JUN-2027 EX NIL80,000TLXAR : PERFORMANCE RIGHTS9,965,235TLXAP : SHARE RIGHTS1,800,000TLXAO : SHARE APPRECIATION RIGHTS14,223,198TLXAT : CONVERTIBLE NOTES3,250TLXAM : OPTION EXPIRING 20-JUL-2026 EX $5.37304,992TLXAN : SHARE RIGHTS EXPIRING 20-JUL-2026 EX NIL100,000TLXAL : OPTION EXPIRING 27-JAN-2026 EX $4.38330,437TLXAS : PERFORMANCE SHARE INCENTIVE RIGHTS440,000

4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)

Appendix 2A - Application for quotation of securities

7 / 7